about
Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal EffectsWSES guidelines for management of Clostridium difficile infection in surgical patientsInfections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention.The novel influenza A (H1N1) virus pandemic: An update.Clostridium difficile infection in Italian urban hospitals: data from 2006 through 2011.Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century.The "delivery" of Adam: a medical interpretation of Michelangelo.Hertoghe sign: a hallmark of lepromatous leprosy.Clostridium difficile 027 infection in Central ItalyCases of cryptosporidiosis co-infections in AIDS patients: a correlation between clinical presentation and GP60 subgenotype lineages from aged formalin-fixed stool samples.Clostridium difficile infection among hospitalized HIV-infected individuals: epidemiology and risk factors: results from a case-control study (2002-2013).Tigecycline Lock Therapy for Catheter-Related Bloodstream Infection Caused by KPC-Producing Klebsiella pneumoniae in Two Pediatric Hematological Patients.Selenium deficiency and HIV infection.Fecal microbiota transplantation: the state of the art.Management of antibiotic resistance in the intensive care unit setting.Extra-cerebral severe infections associated with haemorrhagic hereditary telangiectasia (Rendu-Osler-Weber Disease): five cases and a review of the literature.Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients.Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature.Nosocomial Infections During Extracorporeal Membrane Oxygenation: Incidence, Etiology, and Impacton Patients' Outcome.Fever and Vision Loss in an Immunocompetent 20-Year-Old Male.The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study.Multiple bilateral pulmonary "fungus balls" in an immunocompetent patient unsuitable for surgical treatment: efficacy of azoles treatment.Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia?When an infection prompts removal of an unnecessary device.Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus/flavescens.Carbapenemase-producing Klebsiella pneumoniae-related mortality among solid organ-transplanted patients: do we know enough?Image of the month: 'Diagnostic hands': Janeway lesions.The role of fecal microbiota transplantation in inflammatory bowel disease.Re: The challenge of Clostridium difficile infection: Overview of clinical manifestations, diagnostic tools and therapeutic options.The Protective Role of Albumin in Clostridium difficile Infection: A Step Toward Solving the Puzzle.Telavancin and daptomycin activity against meticillin-resistant Staphylococcus aureus strains after vancomycin-resistance selection in vitroKaposi's sarcoma symmetric mucosal lesionsDengue: Status of current and under-development vaccinesMycobacterium chimaera infections: An update
P50
Q26751477-9D9D21D5-3290-469B-A93D-522A80F15425Q26795429-7C4BDB0A-3570-4937-A51A-7035F5BF845DQ30234400-85CF5C84-1D74-4EF8-8B8F-E19BCE0D7179Q30382148-3273DEDB-E0D0-4602-A444-EE98690D9669Q30605607-8C36800C-B904-4EF2-8FF5-E15C0D2C408BQ30726683-0C27A601-8CAC-49D8-AA16-7E3DFF81B5E0Q34470213-3DC064D3-B9B7-44DF-A98F-65E560744387Q34520225-6B8B1739-7FC3-479C-B570-1DC21C9F40C1Q34520307-296A3DF5-E17F-4BF0-9C5C-F894B8390E3AQ35222537-393521CB-2D68-4528-BE4E-1C8B5B3F064BQ35534395-BD5219DB-C3AF-498B-8D6B-40A0F4E26385Q36290809-87E73100-3919-4E7C-8504-EAC5038FE31FQ37481834-EF7B87DA-5E22-476A-BB82-A444E615A30BQ37481920-A37EBED6-F9AE-4C1E-8D69-AA4BC88F4843Q37700552-8C1DA127-EF96-43AE-A71A-458615F85068Q38197837-C6A9F7FC-313A-4D9F-9B36-50033690EEADQ38363782-74AE564A-8B34-4E7A-B6C2-03212B6EC524Q38486441-2F65B32A-826F-4BDD-BBB2-AB1BE2612102Q38641137-349DEB3E-1EF8-4C4D-9DDE-DBAE4BA3D77FQ40074305-B95045B9-A67A-4E4C-A6E8-CBCA6762194EQ40908537-12E74FA0-C327-483C-BA84-A3C216BE82BCQ42269536-39408BB3-2A74-4B14-9279-13647C351CCDQ43079618-478EDF03-0520-45C1-929B-28FB94F656A7Q43823661-4054157E-8C79-42A8-A126-A13497FD4670Q49360925-F52992BE-0ED9-45D4-B9B2-FBECC9F29230Q51060141-658929C6-743C-4FBA-A8C3-6A1DF10FE112Q53730672-7B16BDF6-E7C9-4E0F-8DB6-CEBD57E7B732Q54227750-34D2A62E-7B70-4525-8D95-D884ED0B0831Q54657693-ACE2E924-3646-4E14-A25C-782532EC0287Q54746258-8512C976-5B66-45CD-ADED-6BE6A454B71DQ58371674-9440DCE0-30D4-4124-A1AF-EC7D2DA0D433Q84364823-DE037939-BA2D-4B4F-A939-87B093D6B5EAQ89893003-FF1D0D07-4719-4CA4-BBD7-D406DECC4063Q92019939-C1421022-B9CF-465B-A4C6-E4914B45F377
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stefano Di Bella
@ast
Stefano Di Bella
@en
Stefano Di Bella
@es
Stefano Di Bella
@nl
Stefano Di Bella
@sl
type
label
Stefano Di Bella
@ast
Stefano Di Bella
@en
Stefano Di Bella
@es
Stefano Di Bella
@nl
Stefano Di Bella
@sl
prefLabel
Stefano Di Bella
@ast
Stefano Di Bella
@en
Stefano Di Bella
@es
Stefano Di Bella
@nl
Stefano Di Bella
@sl
P1053
K-8162-2016
P106
P1153
35221434200
P21
P31
P3829
P496
0000-0001-6121-7009